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Background: Increasing evidence supports a role for altered gene expression in mediating the lasting effects of
cocaine on the brain, and recent work has demonstrated the involvement of chromatin modifications in these
alterations. However, all such studies to date have been restricted by their reliance on microarray technologies that
have intrinsic limitations.
Results: We use next generation sequencing methods, RNA-seq and ChIP-seq for RNA polymerase II and several
histone methylation marks, to obtain a more complete view of cocaine-induced changes in gene expression and
associated adaptations in numerous modes of chromatin regulation in the mouse nucleus accumbens, a key brain
reward region. We demonstrate an unexpectedly large number of pre-mRNA splicing alterations in response to
repeated cocaine treatment. In addition, we identify combinations of chromatin changes, or signatures, that correlate
with cocaine-dependent regulation of gene expression, including those involving pre-mRNA alternative splicing. Through
bioinformatic prediction and biological validation, we identify one particular splicing factor, A2BP1(Rbfox1/Fox-1), which is
enriched at genes that display certain chromatin signatures and contributes to drug-induced behavioral abnormalities.
Together, this delineation of the cocaine-induced epigenome in the nucleus accumbens reveals several novel modes of
regulation by which cocaine alters the brain.
Conclusions: We establish combinatorial chromatin and transcriptional profiles in mouse nucleus accumbens after
repeated cocaine treatment. These results serve as an important resource for the field and provide a template for the
analysis of other systems to reveal new transcriptional and epigenetic mechanisms of neuronal regulation.Background
Alterations in gene expression contribute importantly to
the long-lasting changes that drugs of abuse induce in the
brain’s reward circuitry [1]. Numerous studies to date have
utilized gene expression microarrays to obtain an unbiased
view of such alterations, and several transcription factors
have been implicated in mediating some of these effects.
Moreover, several target genes discovered with these ap-
proaches have been directly implicated in the complex cel-
lular and behavioral plasticity induced in this reward
circuitry associated with drug addiction. However, rela-
tively little information is yet available concerning the de-
tailed molecular steps through which such alterations in* Correspondence: eric.nestler@mssm.edu; li.shen@mssm.edu
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reproduction in any medium, provided the orgene expression are induced, and available information is
limited by the reliance to date on microarray technology.
Recently, epigenetic regulation, such as multiple his-
tone modifications and DNA methylation, has emerged
as a key mechanism of addiction-related phenomena
[2-6]. Drugs of abuse such as cocaine have been shown
to alter the expression levels of several histone- and
DNA-modifying enzymes within key brain reward re-
gions, such as the nucleus accumbens (NAc) [7-10]. Im-
portantly, these enzyme changes, which include altered
levels of certain histone deacetylases and histone lysine
methyltransferases, are associated with cocaine-induced
changes in histone acetylation or lysine methylation at
many specific candidate genes, which are already known
to be involved in cocaine action [9,11]. Recently, cross-talk
has been demonstrated between regulation of histone
acetylation and lysine methylation in NAc [12]. Whiled. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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commensurate with the altered enzyme expression levels,
a large subset of observed changes are in the opposite dir-
ection, which further underscores the complexity of chro-
matin regulation in vivo.
To extend these candidate gene studies, we recently
mapped cocaine-induced changes in the genome-wide
binding of pan-acetylated H3, pan-acetylated H4, and
dimethylated H3 (at both K9 and K27) in NAc by use of
ChIP-chip assays (chromatin immunoprecipitation followed
by promoter microarrays) [13]. This study identified hun-
dreds of novel gene targets of cocaine, but was inherently
limited in several important ways. First, ChIP-chip by de-
sign restricts analysis to proximal promoter regions of
genes only, even though we know that much chromatin
regulation occurs in other genic, as well as intergenic, re-
gions. Second, recent evidence indicates that net levels of
gene transcription result from the complex interplay of
large numbers of chromatin modifications, which act in
concert in ways that remain incompletely understood
[14,15]. Third, genome-wide characterizations of gene ex-
pression in brain have to date relied mainly on microarrays,
as opposed to RNA-seq, which provides unprecedented ad-
vantages such as more precise measurement of levels of
transcripts and their splicing isoforms [16]. Finally, recent
evidence from in vitro non-nervous tissues has suggested
that alternative splicing is regulated by chromatin modifica-
tions at specific genes [17]. As alternative splicing is a
process by which pre-mRNAs are differentially spliced, and
lead to the expression of several mRNAs from a single
gene, it provides an essential mechanism that expands and
diversifies the proteome [18]. However, little is known about
the contribution of alternative splicing to cocaine action or
how it is influenced by epigenetic regulation in brain.
To address these limitations, we carried out a more
comprehensive analysis of the cocaine-induced tran-
scriptome and epigenome in the mouse NAc. We used
ChIP-seq (ChIP followed by next-generation sequen-
cing), which offers several advantages over ChIP-chip
[19], to characterize numerous chromatin modifications
within this brain region in response to repeated cocaine
administration. We focused on several transactivation
marks (H3K4me1, H3K4me3, and H3K36me3) and re-
pression marks (H3K9me2, H3K9me3, and H3K27me3).
These histone modifications were selected to cover enhan-
cer (H3K4me1), promoter (H3K4me3, H3K27me3), gene
body (H3K36me3), and intergenic (H3K9me2, H3K9me3)
regions [20,21]. We also analyzed binding of RNA poly-
merase II (RNA pol II). These ChIP-seq data were then
overlaid onto RNA-seq data to capture cocaine-induced
changes in gene expression, including those resulting from
regulation of pre-mRNA alternative splicing.
Our findings identify many chromatin signatures -
unique combinations of histone modifications that pre-dict cocaine regulation of gene expression, a large por-
tion of which is mediated by previously uncharacterized
changes in alternative splicing. The robustness of this
epigenomic analysis is further demonstrated by its ability
to predict the involvement of a novel splicing factor,
termed A2BP1 (also known as RBFOX1 or FOX-1), in
cocaine action.
Results
Cocaine-regulated transcriptomic changes in mouse
nucleus accumbens
To characterize the transcriptome of mouse NAc, we
used RNA-seq to measure the expression levels of all
polyA containing transcripts in NAc of mice treated
chronically with cocaine or saline (control); we used a
standard treatment regimen of daily 20 mg/kg intraperi-
toneal doses of cocaine for 7 days with animals analyzed
24 h after the last dose, a procedure known to induce
numerous, highly validated molecular and cellular adap-
tations to the drug [9]. This procedure is also behavior-
ally relevant, as it induced locomotor sensitization, an
extensively validated form of behavioral plasticity to re-
peated cocaine administration (Additional file 1). To ac-
count for inter-animal variations, we obtained three
biological replicates for each treatment group, with each
replicate representing NAc pooled from five animals.
Samples were sequenced by an Illumina HiSeq2000 ma-
chine. We obtained 93 to 97 million short reads of 100 bp
from each replicate. Of these, 65 to 67% were successfully
aligned to a reference gene database (Ensembl: Mus mus-
culus, NCBIM37.62) by TopHat [22]. The quality of the
data were assessed by the RNA-SeQC package[23], which
revealed that approximately 95% and 81% of the mapped
reads are intragenic and exonic, respectively, and that the
sequencing data are not overrepresented by mitochondrial
reads (Additional file 2). Overall, our aligned short reads
represent 21,892,637,222 and 21,717,236,397 transcribed
nucleotides for the mouse NAc transcriptome under co-
caine and saline treatment, respectively. These data are
sufficient to provide on average of approximately 183×
coverage for mouse exomes under both conditions.
We used the Cufflinks package [24] to perform differen-
tial analysis for changes in gene expression. For our initial
analysis, we used stringent false discovery rate (FDR) cut-
offs of <10%, fold change >1.25, and Reads Per Kilobase
transcript per Million reads (RPKM) >1, and identified 92
genes (61 increased, 31 decreased; Additional file 3) that
are differentially expressed in NAc after repeated cocaine
administration (see Materials and methods). To confirm
that the expression changes identified reflect the actions
of repeated, not acute, cocaine treatment, we performed
RNA-seq on NAc obtained from mice treated with a sin-
gle dose of cocaine, with animals analyzed 24 h later. The
data were analyzed the same way and passed all quality
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tified 55 genes (42 increased, 13 decreased; Additional file
3) that are differentially expressed in NAc in response to a
single cocaine dose, only 4 of which overlapped with the
chronic cocaine-regulated genes. In addition, two of the
four genes showed the opposite direction of regulation.
We therefore conclude that the vast majority of gene ex-
pression changes induced by repeated cocaine are very dif-
ferent from those induced by acute cocaine.
On average, each protein coding gene in the reference
database encodes 3.4 transcripts. For a coding gene, the
transcripts may share the same transcriptional start site
(TSS; that is, alternative splicing) or have different TSSs
(that is, alternative promoter usage) [25]. Interestingly, our
analysis revealed that promoter usage and splicing changes
are much more widespread than differential expression in
response to repeated cocaine. For this analysis, we used
Cufflinks with an FDR cutoff of only <10% . Although this
approach would be expected to increase the number of
false positive hits, it also reduces the number of false nega-
tive hits, which is important for our subsequent ability to
overlay these RNA-seq data with epigenetic modifications
(see below). This alternative analysis identified 1,772 and
1,739 TSS groups to have alternative promoter usage and
alternative splicing (Additional file 3), respectively, com-
prising approximately 5% of all TSS groups (Figure 1A).
Looking at individual transcripts, we also found 4,129 to
be differentially expressed (Additional file 3), comprising
approximately 5% of all coding transcripts. A few exam-
ples of alternatively spliced genes are shown in Additional
file 4. We validated these RNA-seq data by confirming al-
tered expression of key transcripts in independent tissue
samples by use of Nanostring technology (Figure 2E;
Additional file 5).
Combining the genes that show chronic cocaine-
induced changes in alternative promoter usage or alterna-
tive splicing yields 2,998 genes that are differentially
spliced, which represent 35% of all differentially expressed
genes. To understand the functional roles of these differ-
entially spliced genes, we performed gene ontology (GO)
analysis [27,28] and identified 110 (FDR <10%, Fisher’s
exact test) enriched GO terms (Additional file 6). We cre-
ated an enrichment map [26] (Figure 1B) to represent
these functional terms and found that the differentially
spliced genes are associated with very diverse functions
and cellular components. With respect to molecular func-
tions, two major groups are involved in nucleotide binding
and ion binding, with one minor group participating in
protein localization. In terms of cellular components, four
major groups are involved in membrane enclosed lumen,
actin cytoskeleton, cell junction, and membrane bounded
vesicle, with four minor groups involving chromatin re-
modeling complex, synapse, neuron projection, and mi-
tochondrion. These results suggest that differentiallytranscribed or spliced genes play substantial roles in the
transcriptional perturbations induced in NAc by chronic
cocaine.
Cocaine-regulated epigenomic changes in mouse nucleus
accumbens
The lasting behavioral abnormalities induced by chronic
cocaine treatment have been attributed, in part, to epige-
nomic changes involving post-translational modifications
to histone tails [2,29]. We thus chose six histone modifi-
cations (H3K4me1, H3K4me3, H3K9me2, H3K9me3,
H3K27me3, and H3K36me3), as well as total RNA pol
II, to investigate the epigenomic changes induced in
mouse NAc by repeated cocaine exposure. They were
chosen to ensure coverage of gene promoters, gene bod-
ies, enhancers, as well as intergenic regions and to re-
flect mechanisms of gene activation and repression (see
Background). We used three biological replicates for
each mark, with each replicate again representing tissue
pooled from five animals. After mapping the reads to
the mouse reference genome, we removed the ones
that are redundant at the same location and strand
(Additional file 7). We thereby obtained uniquely
aligned, non-redundant reads with a total number varying
from 8 to 465 million for each of the seven marks under
each condition (Additional file 8). Overall, these ChIP-seq
data represent a highly informative collection of histone
modifications and RNA pol II enrichment, comprising
total read counts of 1,105,314,297 and 1,114,544,836
(Additional file 8) under cocaine and saline treatment,
respectively.
To determine the enrichment for the 42 (7 marks × 2 con-
ditions × 3 replicates) ChIP-seq samples at genic regions, we
generated plots (Figure S4A-G in Additional file 9) at TSSs,
genebodies, and transcriptional end sites using a program
called ngs.plot [30]. The enrichment patterns for the seven
marks from our study are highly similar with those gener-
ated in cell culture studies [21,31], indicating that the ChIP-
seq data are of good quality and that in vivo brain histone
modifications share similar gross distribution patterns with
other tissues. Cocaine does not cause significant changes in
any of these gross distribution patterns (Figure S4A-G in
Additional file 9). We therefore presumed that cocaine-
induced changes are localized to specific genomic sites. To
reveal the location-specific changes for each of the seven
marks, we used diffReps [32] to identify the chromatin
modification sites (termed differential sites) that show sig-
nificant differences between repeated cocaine and saline
conditions. We identified thousands to tens of thousands of
differential sites (ranging from 200 bp to 1,200 bp in size)
for the various marks (FDR <10%; Figure S4H in Additional
file 9; Additional file 10). Together, these differential sites
represent a massive amount of epigenomic changes induced
in mouse NAc by cocaine. Further examination revealed
Figure 1 Chronic cocaine-induced transcriptome in mouse NAc. (A) Cocaine-regulated transcriptomic events versus total events illustrated as
percentages (for example, 92 out of 22,000 genes show significant expression changes), which are based on Cuffdiff prediction (see Materials and
methods). (B) Gene Ontology (GO) enrichment for differentially spliced genes is illustrated as an enrichment map [26]: each node represents an
enriched GO term and its size represents the number of genes; the color intensity of the node represents the statistical significance; the strength
of the green lines represents the number of common genes shared between two nodes; the GO terms that are clustered together are circled
and summarized with a name. Singletons are not shown; a full list of enriched GO terms is in Additional file 6.
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marks at differential sites (Figure S4A-G in Additional file
9). For example, H3K9me2 displays significant dynamics
at its differential sites, with robust increases or decreases
(Figure 3B,C) induced by cocaine despite the fact that it
shows a 'flat-line' like pattern of enrichment at the genebody
level genome-wide (Figure 3A). This further strengthens our
notion that cocaine-regulated chromatin changes are highly
localized and may correspond to specific functions.
e classified all differential sites into several categories based
on their genomic locations (Figure 3D) and found that the
seven marks can generally be divided into the following
groups: 'promoter-centric' (H3K4me3), 'balanced' (H3K4me1
and H3K27me3), 'genebody-centric' (H3K36me3 andRNA pol II), and 'genebody + intergenic' (H3K9me2 and
H3K9me3). The distributions of the differential sites are
very similar to that of basal peaks (Additional file 11) for
these marks. To further elucidate the potential functions
of these chromatin changes, we performed molecular
pathway analysis through IPA (Ingenuity Systems) [33] for
the genes that are associated with the differential sites. In
total, 248 canonical pathways were found to be enriched
(P < 0.05, Fisher’s exact test). To identify the most import-
ant pathways, we ranked them by co-occurrence score
among the seven marks and examined the top 30
(Additional files 12 and 13). We found that many of the
top ranked pathways have been previously implicated in
drug addiction, for example, 'CREB signaling in neurons'
Figure 2 Role of A2BP1 in cocaine responses. (A) Co-immunoprecipitation shows A2BP1 western blotting of H3K4me3 or IgG pulldown of
whole NAc lysate. Two repeated cocaine-treated samples and two saline control samples are shown. (B) The two Venn diagrams show overlap
between: A2BP1-motif containing genes versus H3K4me3 differential site-containing genes (upper); A2BP1 motif- and H3K4me3 differential site-
containing genes versus cocaine-regulated differential and spliced genes (lower). The table shows the top five enriched functional terms of the
478 overlapped genes from the lower Venn diagram. (C) Western blot analysis of A2BP1 in nuclear lysates of NAc after repeated cocaine. Error
bars are mean ± standard error of the mean (SEM) derived from eight cocaine treated and eight saline treated control mice, respectively. (D)
Conditioned place preference (CPP) scores of AAV-Cre-GFP-injected A2bp1loxP/loxP mice (cre) with AAV-GFP-injected A2bp1loxP/loxP mice as control
(con). Error bars are mean ± SEM derived from seven cre and eight control samples. (E) Four predicted A2BP1 target candidate genes were chosen
for Nanostring validation. All show the same direction of transcription change after chronic cocaine treatment as observed in RNA-seq. Error bars are
mean ± SEM derived from 14 cocaine and 14 saline treated samples. (F) Cocaine-induced transcription change as observed in (E) are lost (Rps6kb2, Zfp26,
Dvl1) or in one case reversed (Ece2) when A2bp1 was conditionally knocked down by using AAV-Cre viral injection in NAc. Error bars are mean ± SEM
derived from five cocaine and six saline treated samples. *P< 0.05, **P< 0.01.
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7, score = 28.2), 'synaptic long term potentiation' (top 8,
score = 27.8), and 'WNT/β-catenin signaling' (top 9,
score = 26.5). In addition to the canonical pathways, we
created three customized gene lists to represent additional
knowledge of addiction pathophysiology and also found
them to be enriched: 'actin cytoskeleton' (score = 25.0);
'synaptic plasticity' (score = 17.3); and 'growth factors'
(score = 2.2). This further demonstrates that the chroma-
tin changes we identified are highly specific to brainfunctions that contribute to addiction. Interestingly, the
two marks that are associated with gene activation,
H3K4me3 and RNA pol II, show much more pronounced
enrichment than the other five marks among the top 30
pathways (Additional files 12 and 13).
Chromatin signatures associated with pre-mRNA
alternative splicing
We next determined that the chromatin differential sites
show sharp proximity to exons within a 10 kb window
Figure 3 Repeated cocaine-regulated epigenome measured by ChIP-seq. (A-C) Averaged coverage plots of different biological replicates of
H3K9me2 and DNA input for different genomic regions. The x-axis represents the genomic region from 5’ to 3’. The y-axis represents coverage
that has been normalized to the number of aligned reads per million mapped reads (RPM). (A) Genebody of the entire mouse genome. (B) Differential
sites that show decreased H3K9me2 binding in genic regions. (C) Differential sites that show increased H3K9me2 binding in genic regions. (D) Pie charts
show the genome-wide distribution patterns of the differential sites of the seven chromatin marks.
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seven marks in cocaine-mediated pre-mRNA alternative
splicing. Recent in vitro investigations showed that the
splicing of exons into a mature mRNA occurs co-
transcriptionally [17]. Previous studies have also demon-
strated that some histone marks can act as beacons in
exon definition [34,35] or play important roles in
recruiting splicing factors to pre-mRNAs [36,37]. Wefound in our dataset that all seven marks show local en-
richment at exons to varying degrees and are correla-
ted with transcriptional levels under basal conditions
(Additional file 15). More specifically, exonic enrich-
ments of H3K4me1, H3K4me3, H3K36me3, and total
RNA pol II are positively correlated with transcriptional
levels; that of H3K9me2, H3K9me3, and H3K27me3 are
negatively correlated.
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marks and splicing regulators is complicated. For example,
the repressive mark H3K9me3 has recently been found to
facilitate the inclusion of variant exons of several genes via
a mechanism that involves decreased RNA pol II elong-
ation rate [38]. Another study [37] investigated the roles
of several histone marks in selection of two mutually ex-
clusive exons between two human cell lines, and found
that two groups (H3K27me3, H3K4me3, and H3K9me1
versus H3K36me3 and H3K4me1) of histone marks regu-
late the two exons in the opposite direction. However,
how extensive and how exactly the histone modifications
influence alternative splicing in vivo, especially under
pathological conditions (for example, after chronic cocaine
exposure), is unknown.
RNA-seq provides unique advantages for alternative
splicing analysis [16]. Some programs achieve this goal
by looking at the read counts of individual exons [39,40].
However, transcripts often share common exons whose
read counts thus convey nothing unique about each
transcript’s expression levels. On the other hand, each
transcript must contain unique exonic regions, which
provide information about the transcript’s expression
level. The program we used - Cufflinks - assigns reads
proportionally to each individual transcript by solving an
optimization problem on the unique exonic read counts
[24,25]. In line with this approach, we needed a method
to describe the chromatin changes associated with each
transcript. We therefore devised a systematic approach
called 'chromatin signature' that allowed us to profile
the epigenomic changes associated with each transcript
in a unified fashion (Additional files 7 and 16). In this
analysis, it was important to use our broader Cufflinks
evaluation of differential transcriptional changes, since it
reduces false negative discovery rates, while overlaying
such data with multiple chromatin endpoints achieves
the higher stringency needed to reduce false positive
discovery.
Briefly, we first classified all exons into six different types
(Additional file 16): 'promoter', 'canonical', 'variant', 'alter-
native acceptor', 'alternative donor', and 'polyA'. Each exon
type represents a unique combination of exon-intron
boundaries. We also derived the neighboring intronic re-
gions (150 bp) for each exon, which are also implicated in
splicing regulation [41]. In total, we defined 335,779 and
441,648 unique exonic and intronic regions on the gen-
ome and calculated each mark’s enrichment difference be-
tween cocaine and saline at each region (Additional file 7).
In addition, we included the 500 bp intergenic regions
upstream of the TSS and the enhancers defined by
H3K4me1 peaks (Additional file 7) to complement a chro-
matin signature. We removed the shared regions (that is,
canonical exons and introns at canonical acceptor and
donor sites) from consideration as they do not conveydistinct chromatin information between transcripts. This
results in 13 different types of regions (Additional file 16)
upon which chromatin modifications are defined for a tran-
script. Based on the resulting chromatin signatures, we
constructed a matrix of approximately 77,000 (coding tran-
scripts) × 91 (7 marks × 13 genomic regions; Additional files
7 and 16) to represent the splicing-related chromatin
modifications mediated by cocaine for the entire mouse
transcriptome.
We first tested whether those chromatin signatures can
be grouped by similar patterns and whether they can be as-
sociated with transcriptional changes. To reduce the com-
plexity, we performed genome-wide association (Additional
files 7 and 17) to remove the transcripts that show no de-
tectable chromatin changes. We also removed mark-region
combinations that show little correlation with transcrip-
tional change. Interestingly, we did not find correlations for
the chromatin modifications at the 24,745 H3K4me1-
labeled distal (more than ±1 kb from the TSS) enhancers
and their corresponding target transcripts’ expression
change (Additional file 17). We therefore removed the en-
hancer regions from further analysis. We also found 41
mark-region combinations to be not significant. After this
filtering, we obtained a smaller matrix of approximately
33,000 × 43 and then performed K-means clustering to
identify (Additional file 7) clusters of co-expressed chroma-
tin signatures. We found 29 clusters (Figure 4; P < 0.02,
Fisher’s exact test) to be significantly associated with tran-
scriptional change. Each cluster represents a combination
of enrichment differences of the seven marks (Additional
file 18) that lead to increased or decreased transcript levels
(Figure 4). For example, the H3K4me3 generally shows in-
creased binding around TSSs for clusters 1 to 12. However,
depending on the combination with other histone marks,
clusters 1 to 12 show either increased or decreased tran-
scription (Figure 4). H3K4me1 overall shows decreased
binding at variant and alternative acceptor exons, inclu-
ding neighboring intronic regions across all 29 clusters.
H3K27me3 displays the most dynamics among the seven
marks for the 29 clusters, while H3K9me2 and H3K9me3
only regulate polyA and variant exons, respectively. Not-
ably, most of the marks show regulation at the intronic re-
gions, indicating the importance of introns in determining
splicing.
Functional enrichment analysis through IPA for the 29
signature clusters identified 90 (P < 0.05, Fisher’s exact
test; Additional file 19) enriched biological function terms.
The top 10 functional terms (Figure 5A) based on co-
occurrence score are specific to the nervous system and
neurological diseases or related to some essential cellular
or molecular process. Interestingly, the top ranked bio-
logical functions seem to be ubiquitously enriched among
all signature clusters. On the contrary, the 348 (P < 0.05,
Fisher’s exact test; Additional file 19) enriched canonical
Figure 4 Heatmap of cocaine-regulated chromatin modifications of the 29 signature clusters that associate with transcriptional regulation.
In the left panel, each row represents a cluster and each column represents an epigenomic mark at a specific genomic region; each square
represents the averaged chromatin modification change in log2 scale; purple and orange colors indicate increased or decreased binding and the
darkness indicates the magnitude of change. The heatmap in the right panel illustrates the statistical significance of each cluster’s association
with transcriptional change. N.S., not significant.
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10 are shown), for instance, 'WNT/β-catenin signaling',
'axon guidance signaling', and 'actin cytoskeleton signaling'.
This suggests that cocaine-induced chromatin signature
changes are not random and have functional implications in
drug responses. Furthermore, this indicates that cocaine-
induced transcriptional changes within the same pathway
may share common chromatin signatures, which is cha-
racterized by unique combinatorial histone modification
patterns.
Chromatin signature-associated protein regulators
We next used these chromatin signatures to infer the
types of chromatin-associated proteins that may convert
the epigenetic information into transcriptional change.
The 29 signature clusters we identified represent groups
of transcripts that share common chromatin modifica-
tion patterns. This co-expression indicates that each of
the clusters is co-regulated by a few common protein
regulators that may interact with chromatin during tran-
scription. We focused on transcription factors and spli-
cing factors that may be involved in this process.
To illustrate our approach, an example is given in
Figure 5C-F. Briefly, the region-mark combinations that
show significant chromatin change (P < 1E-10, one groupt-test) in the same direction are first identified from each
cluster. Each transcript is then analyzed and only the regions
that show a significant chromatin binding difference (P <
0.05, one-tailed Student’s t-test) between cocaine and saline
are picked for further analysis. The sequences of the same
type of region (such as variant exon) from the same cluster
are pooled and motif analysis (Additional files 7 and 20) by
MEME [42] is performed. In this manner, we found 32 and
58 uniquely identifiable motifs from the intragenic and inter-
genic regions, representing potential splicing and transcrip-
tion factors that control the 29 clusters, respectively.
The splicing and transcription factors are ranked by
co-occurrence and illustrated as a heatmap (Figure 6,
right panel). Numerous splicing factors identified here
have been reported to have functions in neuronal differ-
entiation, neurological diseases, or synaptic plasticity,
such as ELAVL2 [43,44], ZIC1 [45], A2BP1 (official gene
symbol Rbfox1) [46], and FUS [47,48]. Interestingly, two
E2F family proteins, E2F2 and E2F3, are enriched both
as splicing factors and transcription factors. The E2F
family proteins have been implicated in neurogenesis
[49] and are known to interact with SIRT1 [50], a his-
tone deacetylase that has been implicated in cocaine
regulation [13,51]. Among transcription factors, the top
ranked EGR1 protein is enriched in five clusters and is
Figure 5 (See legend on next page.)
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Figure 5 The functional enrichment of the 29 signature clusters and identification of significant chromatin modification regions for an
example cluster. (A,B) Each row represents a cluster and each column represents a functional term or canonical pathway. The color of each
square represents the statistical significance of enrichment. The enriched terms are ranked by co-occurrence and only the top 10 are shown. (A)
Biological functions. (B) Canonical pathways. N.S., not significant. (C) The chromatin modification heatmap for cluster 9. Each column represents
a transcript and each row represents a chromatin mark at a specific genomic region. Only 10 example transcripts are shown here. Each square
represents the chromatin change in log2 scale. The transcriptional change is simply indicated as a binary value. The significantly modified regions
are marked by asterisks to the right of their names. An example transcript, ENSMUST00000141539 of gene Dvl1 (a protein in the WNT/β-catenin
pathway), is further illustrated in (D-F). (D) Genome browser screenshot for the demo transcript with H3K4me3 and H3K27me3 in the top and
bottom two tracks, respectively. The exon structures of the demo transcript and another transcript of the same gene are shown below the chromatin
tracks. The genomic regions are marked by letters ('u', upstream intergenic; 'p', promoter exon; 'c', canonical exon; 'v', variant exon; 'i', intron), and are
further followed by numbers to distinguish different regions. (E,F) Mean and standard error of the mean of the significant regions with some neighbors
are shown as line plots with error bars. The x-axis represents different regions from 5’ to 3’ and the y-axis represents normalized coverage. (E) H3K4me3
at u, p, i1, i2 and c. (F) H3K27me3 at v1, i3, i4, v2 and i5.
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the direct regulation of its target genes [52]. Notably,
only one splicing/transcription factor, ZIC1, shows dif-
ferential expression in our RNA-seq data, suggesting
that cocaine mainly regulates the target genes via their
interaction with perturbed chromatin modifications at
the target loci. The epigenomic marks that interact with
the splicing factors are shown as a heatmap (Figure 6,
left panel), where H3K27me3 and H3K4me3 display a
dominant presence. The only mark that interacts withFigure 6 Splicing and transcription factors inferred from the 29 signa
epigenomic marks. Splicing and transcription factors are indicated on the
splicing factor on the left; red means the enrichment of a transcription fact
factors and the top 32 transcription factors are shown here. Each column repr
labeled as 'Very High' (RPKM >20), 'High' (RPKM >5 and ≤20), 'Medium' (RPKM >
marks that interact with the splicing factors are shown on the left panel by pinktranscription factors at upstream intergenic regions is
H3K4me3, which shows increased enrichment after
cocaine.
A2BP1 is an important regulator of cocaine responses
As noted above, our motif analysis identified A2BP1 as a
potentially important splicing factor that regulates clus-
ters 8 and 9 (Figure 6). A2BP1 belongs to a family of
RNA binding proteins that is composed of two other
homolog splicing factors, RBFOX2 (RBM9 or FOX-2)ture clusters induced by repeated cocaine and their interacting
right panel by different colors. Green means the enrichment of a
or on the right; blue means the enrichment of both. All 32 splicing
esents a signature cluster. The gene expression level for the regulators is
1 and ≤5), and 'Low' (RPKM ≤1) based on our RNA-seq data. The chromatin
color.
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A2BP1 was first identified through its interaction with
Ataxin-2, the protein mutated in spinocerebellar ataxia
type II [53]. Mutations in the human A2BP1 gene have
since been associated with several other neurological
syndromes, including mental retardation, epilepsy, and
autism spectrum disorders [54-57]. Recent studies also
implicate A2BP1 in regulating neuronal excitability as well
as neuronal adaptations to stress [58,59]. Our RNA-seq
data demonstrated that A2bp1 is highly expressed in
mouse NAc (RPKM= 90, >97% of the genome in NAc).
By binding to the CAUGCA motif, A2BP1 controls many
neuronally regulated exons [60]. Indeed, some A2BP1-
dependent alternative exons have already shown dysregu-
lated splicing in human autism spectrum disorders [61].
In clusters 8 and 9 (Figure 6), the site of discovery for
the A2BP1 motif is located in promoter exons where
H3K4me3 shows increased binding after cocaine. This in-
dicates an interaction between this splicing factor and the
histone tail modification, which has not to date been doc-
umented. We first validated such H3K4me3 enrichment at
selected loci from clusters 8 and 9 with ChIP-quantitative
PCR (Additional file 21). Next, we experimentally exam-
ined the physical binding between the two molecules. A
co-immunoprecipitation assay demonstrated a significant
enrichment of A2BP1 in the H3K4me3 immunoprecipita-
tion pulldown from NAc extracts (Figure 2A). Notably,
this binding between A2BP1 and H3K4me3 appeared to
be specific, since no A2BP1 was detected in the IgG pull-
down control samples.
We then performed a genome-wide scan [62] for the
A2BP1 motif obtained from our analysis on the regions
where the chromatin signatures were defined in this
study, and found 37,993 hits (motif match P < 1E-4). We
further intersected the genes whose exons or introns
contain a predicted A2BP1 binding motif (n = 11,874)
with the genes that contain H3K4me3 differential sites
(n = 3,994) and found the overlap (n = 2,463) to be statis-
tically significant (Figure 2B; P = 6E-45, Fisher’s exact
test). This finding further strengthened the enrichment
of A2BP1 at cocaine-regulated H3K4me3 binding sites.
Moreover, the genes that display a significant A2BP1
and H3K4me3 interaction (n = 2,463) also show substan-
tial overlap (Figure 2B; P = 1E-25, Fisher’s exact test)
with cocaine-regulated genes (n = 2,866), including those
displaying differential expression or alternative splicing.
IPA analysis of the 478 cocaine-regulated, A2BP1-
H3K4Me3 interaction genes (Figure 2B; Additional file
22) revealed 174 functional terms to be enriched (P =
0.05, Fisher’s exact test; Additional file 23), with the top
five terms (Figure 2B) relating to neurite formation and
synapse dynamics.
Though our RNA-seq data did not show significant
cocaine regulation of A2bp1’s mRNA levels, we usedwestern blotting to test whether chronic cocaine treat-
ment alters A2BP1 at the protein level in NAc. Consist-
ent with the mRNA finding, we did not observe a
significant change of A2BP1 from whole NAc lysates
(data not shown). However, chronic cocaine induced a
>2.5-fold increase in A2BP1 protein levels in nuclear ly-
sates (Figure 2C). This nucleus relocation is consistent
with previous findings from cultured neurons that
depolarization induces nuclear migration of A2BP1,
which increases the splicing of A2BP1 target genes [60].
To gain further insight into the functional importance
of A2BP1 in behavioral responses to cocaine, we carried
out conditioned place preference (CPP) assays in mice
with a local knockout of A2bp1 from NAc. CPP provides
an indirect measure of drug reward. Adult floxed A2bp1
(A2bp1loxP/loxP) mice [58] were injected intra-NAc with an
adeno-associated virus (AAV) vector expressing Cre-GFP
or GFP alone. Though AAV-GFP-injected A2bp1loxP/loxP
mice developed a significant cocaine preference at a mod-
erate drug dose (7.5 mg/kg), AAV-Cre-GFP-injected
A2bp1loxP/loxP mice displayed no place conditioning
(Figure 2D). Thus, knockdown of A2bp1 in NAc de-
creased the rewarding effects of cocaine.
Lastly, we selected representative predicted A2BP1tar-
get genes within clusters 8 and 9 and tested whether
conditional A2bp1 knockdown in NAc affects their ex-
pression. Consistent with our RNA-seq data, by use of
Nanostring validation with independent tissue samples,
we confirmed increased expression of Rps6kb2 and
Zfp26, as well as decreased expression of Dvl1 and Ece2
(Figure 2E). Importantly, all of these chronic cocaine-
triggered expression changes were lost when A2bp1 was
conditionally knocked down in NAc; in fact, Ece2 dis-
played cocaine regulation in the opposite direction in
the absence of A2bp1 (Figure 2F). These findings further
support the importance of this splicing factor in cocaine
action as inferred from our bioinformatic analyses.
Conclusion and discussion
Results of the present study provide the most complete pro-
filing to date of the cocaine-induced transcriptome and epi-
genome in NAc. We defined the binding patterns of six
histone modifications and of RNA pol II genome-wide
under repeated cocaine and saline conditions and correlated
these patterns with the repeated cocaine-induced transcrip-
tome. We show that different histone modifications act in a
combinational fashion to create chromatin signatures that
correlate with altered gene expression and, more specifically,
with dramatic cocaine regulation of alternative splicing.
These findings not only provide fundamentally new insight
into the mechanisms by which repeated exposure to cocaine
regulates gene transcription in NAc, but they also provide
important information concerning the basic mechanisms of
transcriptional regulation in the brain in vivo.
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emerged as a powerful means for characterizing the
functional consequences of chromatin structure [15].
However, most available studies are derived from cul-
tured cell systems during differentiation, development,
or reprogramming. Whether similar rules defined in
these homogeneous cell populations in vitro also apply
to the brain in vivo is the key step to expand future epi-
genetic research. Our profiling of multiple histone marks
in mouse NAc thus presents a much needed public ref-
erence resource for the neuro-epigenome, as well as de-
tailed knowledge of global chromatin changes that occur
in a discrete region of adult brain in response to re-
peated cocaine administration. We found that the basal
patterns of the six histone marks studied are similar to
those demonstrated in simpler systems. However, within
these constraints, cocaine induced robust modifications
in each of these marks at numerous genes and non-
genic loci. We also found that the various histone marks
carry different weights for transcriptional regulation, and
that the combinatory pattern of modifications (chromatin
signature) ultimately defines the transcriptional response.
Our expectation is that analysis of still additional histone
modifications will yield an ever more comprehensive and
accurate epigenetic regulation network. Selective analysis
of the cocaine-induced epigenomes of the several neuronal
and non-neuronal cell types in NAc, something not yet
technically feasible, would further improve our under-
standing of such networks. Nevertheless, our findings to
date highlight the power of histone modification profiling
for identifying diverse functional groups and target genes
involved in cocaine action.
An unexpected finding of our study is the dominant con-
tribution of changes in alternative splicing induced in NAc
in response to chronic cocaine. In contrast to approxi-
mately 100 genes that show cocaine regulation of total
transcript levels, we demonstrated an order of magnitude
more genes that display altered splicing. These data indi-
cate that previous studies that relied on microarray analysis
and thereby focused on total gene transcription without
discrimination of isoform differences dramatically underes-
timated the degree to which cocaine modifies the NAc
transcriptome. Alternative pre-mRNA splicing is a major
source of protein diversity in higher eukaryotes, a process
particularly important for genes expressed in the brain
[18,63,64]. Though there have been sporadic papers on
splicing regulation of particular genes in addiction models
[65-67], the present study is the first comprehensive ana-
lysis of splicing regulation in response to chronic cocaine.
Given the fact that products of different splicing isoforms
often serve unique cellular functions, the characterization
of individual transcripts instead of the whole gene repre-
sents an important advance for understanding the molecu-
lar adaptations that underlie cocaine action.Though alternative splicing was traditionally thought to
be a post-transcriptional event, based largely on the pri-
mary sequence of the RNA, recent research has demon-
strated that pre-mRNA splicing is intimately linked to
transcription and the chromatin architecture of the gene
[17]. The spliceosome is proposed to physically link to the
transcriptional machinery through interactions between
splicing factors and RNA pol II, and specific histone modi-
fications have been shown to regulate alternative splicing
in cell culture. For example, depolarization of cultured
neurons triggers the skipping of exon 18 of the neural cell
adhesion gene, a change accompanied by H3K9 hyper-
acetylation around the exon [68]. The effect of depola-
rization can be further potentiated by treating the cells
with a histone deacetylase inhibitor. As another example,
the fibroblast growth factor receptor 2 (Fgfr2) gene is al-
ternatively spliced into two isoforms, Fgfr2-IIIb and -IIIc
[37]. The gene is enriched with H3K36me3 and H3K4me1
along the alternatively spliced region in mesenchymal cells
where exon IIIc is transcribed, and with H3K27me3 and
H3K4me3 in epithelial cells where exon IIIb is transcribed.
Importantly, modulation of H3K36me3 or H3K4me3
levels by overexpression or down-regulation of their re-
spective histone methyltransferases changes the tissue-
specific alternative splicing pattern in a predictable fashion
in cultured cells [37]. These observations suggest that lo-
calized changes in histone modification signatures along
an alternatively spliced region can change splicing out-
come. Furthermore, it provides a novel means of regu-
lating gene transcription (splicing) through epigenetic
manipulation.
However, studies to date have been mainly performed in
cell culture with a candidate gene approach. How histone
modifications relate to alternative splicing at a more global
level, within the brain in vivo and in response to environ-
mental stimuli, remains unknown. By obtaining genome-
wide maps of several histone modifications within a
discrete region of brain under chronic cocaine conditions
coupled with genome-wide analysis of alternative splicing
patterns, we have identified 29 chromatin signatures that
differentially predict alterations in gene expression and,
more specifically, regulation of alternative splicing. The
genes are highly concentrated in certain functional groups.
These findings indicate that control of pre-mRNA alterna-
tive splicing by histone modifications is a general feature
of biological regulation. Moreover, an unbiased motif ana-
lysis inferred unique sets of transcription factors and spli-
cing factors that are associated with individual chromatin
signatures.
As a proof of principle, we selected to further analyze
one candidate splicing factor, A2BP1, which has not pre-
viously been studied in cocaine action. A2BP1 is a
neuron-specific splicing factor that promotes either exon
inclusion or skipping. It has been implicated in several
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as autism spectrum disorder, mental retardation, epilepsy,
bipolar disorder, and schizophrenia [69]. The protein kin-
ase WNK3 binds to A2BP1 and suppresses its splicing ac-
tivity through a kinase activity-dependent cytoplasmic re-
localization of A2BP1 [70]. Our observation of nuclear
translocation of A2BP1 after repeated cocaine exposure
suggests a robust role of A2BP1 in alternative splicing
even though there is no change in total cellular levels of
the protein. Increased nuclear levels of A2BP1 might fa-
cilitate adaptive alterations of pre-mRNA splicing of
A2BP1 target transcripts that affect cocaine responses.
Analysis of brain-specific A2bp1 knockout mice revealed
altered synaptic transmission, increased membrane excit-
ability, and a predisposition to seizures [58]. Though few
changes are seen in total transcript abundance, A2bp1-de-
ficient brain displays a variety of splicing changes related
to genes mediating synaptic transmission and membrane
excitability. Similar implication of A2BP1 targets in neural
transmission, neuronal development, and maturation genes
has been demonstrated in autism spectrum disorder and
human neural stem cell studies [61,69]. Through bioinfor-
matic analysis, our genome-wide data predicted that A2BP1
associates with H3K4me3 in concert with the regulated
splicing of target genes after repeated cocaine administra-
tion. Indeed, we verified that A2BP1 is associated with
H3K4me3 in NAc in response to repeated cocaine adminis-
tration. Moreover, we show that conditional knockdown of
A2bp1 from the adult NAc dramatically impairs rewarding
responses to cocaine, and we confirmed regulation of sev-
eral predicted A2BP1 target genes in NAc whose regulation
by repeated cocaine is lost upon knockdown of this splicing
factor. In the future, it will be interesting to further investi-
gate the mechanisms by which cocaine triggers A2BP1
translocation to the nucleus and the means underlying
A2BP1 regulation of its gene targets, work which will con-
tribute to a better understanding of the molecular mechan-
ism of cocaine action.
It is important to emphasize that sequencing data ob-
tained from brain is inherently noisier than that obtained
from simpler systems such as cultured cells. One prom-
inent example is Ttr, which encodes transthyretin, im-
portant for thyroid hormone and retinol transport. It is
highly enriched in choroid plexus [71], although expres-
sion in retina and certain central neurons has been re-
ported [72,73]. As can be seen from Additional file 24,
although our differential analysis shows that chronic co-
caine regulates Ttr expression in NAc, this conclusion
must be viewed with caution given the great variability
in the cocaine and saline replicates. We therefore ana-
lyzed our entire differential gene list for genes that show
similar large variance. Only three and two of the regu-
lated genes show such variability in acute and chronic
data, respectively, which underscores the importance ofutilizing multiple statistical tests when evaluating RNA-
seq datasets. The analyses also demonstrate that the dif-
ferential lists reported in this study are generally sound,
as substantiated further by the several levels of valid-
ation provided. Meanwhile, the source of the variability
seen in Ttr and a small fraction of other genes remains
unknown. One possible source of variability might be
dissections of NAc. To gain insight into this possibility,
we analyzed classes of genes known to be expressed ei-
ther at very high levels or at relatively low levels in NAc
versus surrounding brain regions, including the choroid
plexus (Additional file 25). Among a list of over 100
choroid plexus-enriched genes [74] compared to stri-
atum, only Ttr shows high variability; all of the others
are consistently depleted in our datasets. The data also
reveal strong consistency across replicates for NAc-
enriched and -depleted genes. Thus, while dissecting a
micronucleus from brain by necessity introduces some
variability, these data argue for considerable consistency
in our dissections. The analysis does, however, highlight
systematic differences in expression levels of some genes
seen across experiments: replicates are highly consistent
within one experiment (for example, acute saline) but
vary more between experiments (for example, acute ver-
sus chronic saline). Such 'batch' effects may reflect the
different basal state of animals used at different times of
experimentation, variability that is inherent in any in vivo
experiment.
In any event, the results of this study confirm the im-
portant insight provided by the multiple platforms of ana-
lysis undertaken to better understand how repeated
exposure to cocaine alters gene expression in NAc. By fur-
ther mining these data, and carrying out similar analyses
at different time points of cocaine exposure and cocaine
treatment paradigms with additional epigenetic marks, it
will be possible to ultimately explore the complete com-
plex program of gene regulation that underlies important
aspects of drug addiction.
Materials and methods
Cocaine treatment and nucleus accumbens dissection
Adult male C57BL/6 J mice (Jackson) 8 weeks old were
used in this study. They were housed five per cage on a
12-h light-dark cycle at constant temperature (23°C)
with free access to food and water ad libitum. Animals
were habituated for at least 1 week before experimenta-
tion. For repeated cocaine treatment, animals received
daily intraperitoneal injections for seven consecutive
days of cocaine (Sigma-Aldrich, St. Louis, MO, USA) at
20 mg/kg body weight ('repeated cocaine'). Mice were
used 24 h after the final injection. For acute cocaine
treatment, mice received only one injection of cocaine at
20 mg/kg body weight on day seven after six daily intra-
peritoneal saline injections. Control mice for all groups
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14-gauge NAc punches were taken from each animal
24 h after the last injection. All animal protocols were
approved by the Institutional Animal Care and Use
Committee of Mount Sinai.
Locomotor activity assay
Mouse locomotor activity was tested as previously de-
scribed [8]. In brief, mice were injected with saline or co-
caine (20 mg/kg) at the same time each day and placed in
standard rat cages located inside a Photobeam Activity
System (San Diego Instruments, San Diego, CA, USA).
On day 0, mice were habituated to the cage for 30 minutes
and then given a saline injection. On days 1 to 7, mice
were given injections of cocaine. Horizontal ambulation
was measured for 30 minutes after all injections.
RNA-seq
Brain samples were homogenized in Trizol and processed
according to the manufacturer’s instructions. RNA was
purified with RNeasy Micro columns and Bioanalyzer con-
firmed that the RNA integrity numbers were >8.0. Total
RNA (4 μg) was used for mRNA library construction fol-
lowing instructions of Illumina mRNA sample prep kit
(catalog number RS-100-0801). Please refer to Additional
file 7 for details. The RNA-seq read alignment and differ-
ential analysis were done using TopHat [22] and Cufflinks
[24] packages. For our initial analysis, cutoffs were set as
FDR <10%, fold change >1.25, and RPKM >1 for treatment
and control groups. For subsequent broader analyses, we
used an FDR cutoff of only <10%.
ChIP-seq
ChIP was performed as previously described [9,13]. Anti-
bodies were all ChIP grade from Abcam, Cambridge, MA,
USA. Around 10 nanograms of input DNA or pull-down
DNA were used for sequencing library preparation following
the instructions of Illumina’s ChIP-seq sample prep kit (cata-
log number IP-102-1001). Please refer to Additional file 7
for details. The ChIP-seq read alignment was done using
Illumina’s CASAVA pipeline. Please refer to Additional file 7
for details on further filtering. Differential analysis was done
by diffReps [32] with window size 200 bp and moving size
20 bp. A FDR <10% was used as the significance cutoff. Glo-
bal visualization for the ChIP-seq data was accomplished
with a program called ngs.plot [30] (Additional file 7). Basal
level peak calling was carried out using MACS [75] with the
three saline replicates pooled and DNA input samples used
as background.
Chromatin signatures
The reference gene database was analyzed to extract the
genomic coordinates for the six types of exons and
neighboring intronic regions. These genomic coordinateswere then compared against the ChIP-seq alignment
files to determine the fold changes that were further as-
sembled into chromatin signatures for clustering (see
Additional file 7 for more details).
Nuclear protein isolation, co-immunoprecipitation,
and western blotting
Nuclear protein isolation was done following a published
protocol [76]. Please refer to Additional file 7 for details.
Immunoprecipitation was performed following a standard
protocol with H3K4me3 antibody from Millipore, Billerica,
MA, USA. Either nuclear protein or immunoprecipitated
proteins were used for western blotting as described previ-
ously [76]. Antibodies used in this experiment were A2BP1
(1:500; Abcam) and histone 3 (1:1,000; Abcam).
Nanostring assay
High quality RNA (RNA integrity number >8) was se-
lected based on bioanalyzer examination. Up to 1,000 ng
of total RNA samples were submitted to NanoString for
analysis with the Gene Expression Assay. The code set
was designed by the company with unique sequences.
Raw counts for each assay were collected and normal-
ized with the NanoString data analysis software nSolver.
Both positive control and reference housekeeping genes
were utilized for normalization of read counts.
A2bp1 knockout mice, stereotaxic surgery, and
conditional place preference
Adult (6 to 8 weeks old) A2bp1loxP/loxP mice were pur-
chased from Jackson (stock number 014089) [58]. AAV-
Cre and AAV-GFP vectors were used, and stereotaxic
intra-NAc injections were performed, as reported [77].
Viral injection sites were verified by confirming the GFP
signal in NAc slices under the microscope. Viral knock-
down of A2bp1 was confirmed using quantitative PCR.
A standard, unbiased CPP procedure was utilized as de-
scribed [77]. In brief, 3 to 4 weeks after viral injection,
when AAV-mediated expression is maximal, animals were
pretested for 20 minutes in a photo-beam monitored box
with free access to environmentally distinct chambers.
The mice were then arranged into control and experimen-
tal groups with balanced pretest scores. Then mice under-
went four 30-minute training sessions (saline in the
morning and cocaine in the afternoon) over two days. On
the test day, mice had 20 minutes of unrestricted access to
all chambers and a CPP score was assigned by subtracting
the time spent in the cocaine-paired chamber from the
time spent in the saline-paired chamber. Cocaine was
injected intraperitoneally at 7.5 mg/kg.
Data access
All the ChIP-seq and RNA-seq data have been deposited
into the Gene Expression Omnibus with accession
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cates 1 and 2 and saline replicates 1, 2, and 3 of the
H3K9me3 ChIP-seq, which were previously deposited in
the Gene Expression Omnibus, submission GSE24850.Additional files
Additional file 1: Figure S1. Locomotor sensitization to repeated
cocaine. Mice received daily cocaine (20 mg/kg) or saline injections for
7 days and were evaluated for locomotor activity on days 1, 3, and 7. A
significant (two-way ANOVA) main effect of day (F2,36 = 4.47, P < 0.01)
and drug (F1,36 = 36.37, P < 0.0001) and an interaction between day and
drug (F2,36 = 7.38, P = 0.002) was observed (cocaine, N = 8; saline, N = 12).
Bonferroni post hoc analysis reveals significant increases in locomotor
activity after cocaine versus saline on days 1 and 3 (*P< 0.01) and significantly
greater activity on day 7 versus day 1 (**P < 0.01). Data are presented as
mean ± standard error of the mean.
Additional file 2: Table S1. RNA-seq quality control metrics for acute
and chronic data.
Additional file 3: Table S2. Differential RNA-seq lists. Differential gene
lists from repeated and acute cocaine RNA-seq experiments; differential
splicing lists from repeated cocaine RNA-seq experiments. Cuffdiff was
used to perform differential analysis for various transcriptomic events.
Additional file 4: Figure S2. Sample splicing screenshots. Genome
browser screenshots of alternative splicing examples from chronic
cocaine RNA-seq experiments. The red and green tracks represent normalized
RNA-seq coverage in cocaine and saline. The data scale is the same for both
cocaine and saline. The schemes of an alternatively spliced transcript and a
contrast transcript are shown at the bottom. The black boxes highlight the
alternative regions that show different expression changes from the rest of
the gene body. The asterisk indicates that the isoform is predicted to be
significantly changed. FC, fold change. (A) Ttc23: ENSMUST00000107470 (or
TCONS_00070790), log2 FC = 3.7, q-value = 2E-4; ENSMUST00000126093 (or
TCONS_00070785), log2 FC=0.7, q-value=0.7. (B) Sp100: ENSMUST00000147552
(or TCONS_00001011), log2 FC=2.8, q-value=0.01; ENSMUST00000153574 (or
TCONS_00001012), log2 FC=1.3, q-value=0.7. (C) Sept7: ENSMUST00000115272
(or TCONS_00079740), log2 FC=−0.3, q-value=0.007; ENSMUST00000060080 (or
TCONS_00079741), log2 FC=0.3, q-value=1.
Additional file 5: Figure S3. RNAseq nanostring validation. Nanostring
validation of cocaine-induced changes in RNA expression in NAc. A separate
cohort of animals was used to validate RNA-seq results. Normalized Nanostring
read counts are shown on the y-axis. All genes display the same direction of
change with significance as seen with RNA-seq. Error bars are mean ± standard
error of the mean derived from 14 cocaine treated and 14 saline
treated samples. *P < 0.05, **P < 0.01.
Additional file 6: Table S3. GO term enrichment of genes that have
altered splicing. The altered splicing group combines the genes that
contain alternative promoter usage and/or alternative splicing. DAVID is
used to perform GO analysis. Only three GO categories are used:
biological process, cellular component, and molecular function.
Additional file 7: Extended experimental procedures.
Additional file 8: Table S4. ChIP-seq sample read statistics. #Uniq =number
of uniquely aligned reads; #Rmdup=number of reads after removing duplicates
(Additional file 7); #TotRead= total number of reads combining three replicates;
#TotNuc= total number of nucleotides.
Additional file 9: Figure S4. Global enrichment plots and numbers of
differential events. Each panel includes five sub-figures for the enrichment,
using data pooled from the three biological replicates, of an epigenomic
mark at TSSs, gene bodies, transcriptional end sites, and cocaine up-regulated
sites and down-regulated sites. Y-axes represent the normalized coverage
(RPM) that is averaged across all genomic regions. (A) H3K4me1. (B) H3K4me3.
(C) H3K9me2. (D) H3K9me3. (E) H3K27me3. (F) H3K36me3. (G) RNA pol II.
(H) Number of differential events for the seven epigenomic marks.
Additional file 10: Table S5. Differential sites for the seven epigenomic
marks. diffReps is used to identify differential sites for each of the sevenepigenomic marks. A FDR cutoff of <10% was used to choose the sites
that are significant.
Additional file 11: Figure S5. Distribution of basal peaks for the seven
epigenomic marks. (A) H3K4me1. (B) H3K4me3. (C) H3K9me2. (D)
H3K9me3. (E) H3K27me3. (F) H3K36me3. (G) RNA pol II.
Additional file 12: Figure S6. Heatmap showing the enrichment of the
top 30 and custom pathways among the seven marks. The darkness of
each grid represents the statistical significance of enrichment.
Additional file 13: Table S6. Enrichment analysis of ChIP-seq differential
sites. After the differential sites are mapped to promoter or gene body, the
genes that contain the differential sites are uploaded to IPA for enrichment
analysis. The enriched canonical pathways or customized gene lists
are extracted. Each value represents -log10(P-value) of enrichment.
Co-occurrence score (Additional file 7) is used to rank the pathways
in descending order.
Additional file 14: Figure S7. Differential sites to exon center distance
density plots (related to Figure 3). The distance between each differential
site and the closest exon center was calculated. The exons were further
classified into three categories: promoter, internal, and polyA. The density
for the distance within a 10 kb window of the exon center of each type
was calculated. Each panel represents an epigenomic mark. (A) H3K4me1.
(B) H3K4me3. (C) H3K9me2. (D) H3K9me3. (E) H3K27me3. (F) H3K36me3.
(G) RNA pol II.
Additional file 15: Figure S8. Coverage plots for the seven marks at six
different types of exons (see main text). The exons are further classified
based on the RNA-seq RPKM of the corresponding transcript: 'High' (≥10),
'Medium' (≥1 and <10), and 'Low' (<1). (A) H3K4me1. (B) H3K4me3. (C) H3K9me2.
(D) H3K9me3. (E) H3K27me3. (F) H3K36me3. (G) RNA pol II.
Additional file 16: Figure S9. Construction of cocaine-induced chromatin
signatures. All chromatin signatures are put into a signature matrix with each
row being a transcript and each column being the log fold change of each
mark at each genomic region. K-means clustering was performed on the
signature matrix to group transcripts into signature clusters that share common
chromatin modification patterns. The regions that show significant chromatin
changes were extracted to perform motif analysis to identify potential splicing
and transcription factors.
Additional file 17: Table S7. Genome-wide association between chromatin
modification and transcriptional change. Based on the chromatin modification
at each genomic region, transcripts are separated into up-regulated, down-
regulated, and non-significant (Additional file 7). The chromatin-up and -down
transcripts are correlated with transcripts that show expression change using
Fisher’s exact test. This generates four combinations ('s' = chromatin modification,
'e' = expression change): s.up.e.up; s.up.e.down; s.down.e.up; s.down.e.down. The
P-values were adjusted using the BH [78] method and a FDR cutoff of <10% was
used to select mark-region combinations. The analysis was first done with the
enhancer regions included and then repeated with the enhancers removed.
Additional file 18: Figure S11. Chromatin modification heatmap for 29
signature clusters. A merged heatmap for all 29 signature clusters with
transcripts as rows and mark-region combinations as columns. The color
key indicates log2 fold changes. Different clusters are labeled by different
colors.
Additional file 19: Table S8. Enriched functional terms and canonical
pathways among the 29 signature clusters. IPA was used to find the enriched
biological functions and canonical pathways among the signature clusters.
The co-occurrence score was then used to rank the enriched terms in descending
order.
Additional file 20: Motif intermediate results. This zip file contains
the textual outputs from motif analysis. The motifs found by MEME [42]
were first combined using the Bayesian motif clustering [79] method and
then matched with known motifs. Further explanations are provided in
the enclosed README file.
Additional file 21: Figure S10. Quantitative ChIP validation of cocaine-
induced changes in H3K4me3 in NAc. A separate cohort of animals was
used to validate ChIP-seq data. All genomic sites tested display the same
direction of change with significance as seen with ChIP-seq. Error bars
are mean ± standard error of the mean derived from 8 to 14 replicates
per condition. *P < 0.05, **P < 0.01.
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that are also cocaine-regulated.
Additional file 23: Table S10. A2BP1 H3K4me3 cocaine-regulated gene
functional enrichment. Functional enrichment for the genes in Additional
file 22. IPA was used to identify enriched biological functions for the genes
listed in Additional file 22 restricted to the central nervous system.
Additional file 24: Table S11. Inter-replicate variability of differential
genes. Variability was measured by the coefficient of variance (CV), which
equals the mean divided by the standard deviation. The mean and CV
values for both cocaine and saline conditions are shown.
Additional file 25: Table S12. Quality control of RNA-seq data. RPKM
values are shown for the three saline samples from the acute experiment
and from the chronic experiment. MSN-enriched genes: genes known
from previous studies to be enriched in striatal (including NAc) medium
spiny neurons. MSN-depleted genes: genes encoding related neurotransmitter
and neuropeptide system products known from previous studies to be expressed
at low levels in NAc. Choroid plexus-enriched genes: genes known from previous
studies to be enriched in choroid plexus, although many of these genes are also
known to be expressed in neurons.
Abbreviations
AAV: adeno-associated virus; bp: base pair; ChIP: chromatin immunoprecipitation;
CPP: conditioned place preference; GFP: green fluorescent protein; GO: gene
ontology; NAc: nucleus accumbens; PCR: polymerase chain reaction; RNA polII: RNA
polymerase II; TSS: transcriptional start site.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
EJN, LS, and JF conceived and designed the experiments. LS provided analytic
tools and analyzed the data. XL, IP, NS, JF, and EJN participated in ChIP-seq and
RNA-seq data analysis. JF and MW generated the RNA-seq and ChIP-seq data. JF
performed the nanostring, quantitative PCR, and quantitative ChIP experiments.
DF, JF, and MC performed nuclear protein isolation, co-immunoprecipitation and
western blotting. JF, VV, and JK carried out stereotaxic surgery and CPP experiments.
QL contributed locomotor data. DF, VV, IM, PK, CD, BL, VS, and QL participated in
generating various datasets. LS, JF, and EJN wrote the manuscript. All authors read
and commented on the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported by P01 DA008227 from the National Institute on
Drug Abuse (EJN).
Received: 8 August 2013 Accepted: 22 April 2014
Published: 22 April 2014
References
1. Nestler EJ: Molecular basis of long-term plasticity underlying addiction.
Nat Rev Neurosci 2001, 2:119–128.
2. Robison AJ, Nestler EJ: Transcriptional and epigenetic mechanisms of
addiction. Nat Rev Neurosci 2011, 12:623–637.
3. Day JJ, Sweatt JD: DNA methylation and memory formation. Nat Neurosci
2010, 13:1319–1323.
4. Peixoto L, Abel T: The role of histone acetylation in memory formation
and cognitive impairments. Neuropsychopharmacology 2013, 38:62–76.
5. Jonkman S, Kenny PJ: Molecular, Cellular, and Structural Mechanisms of
Cocaine Addiction: A Key Role for MicroRNAs. Neuropsychopharmacology
2013, 38:198–211.
6. Feng J, Nestler EJ: Epigenetic mechanisms of drug addiction. Curr Opin
Neurobiol 2013, 23:521–528.
7. Renthal W, Maze I, Krishnan V, Covington HE, Xiao G, Kumar A, Russo SJ,
Graham A, Tsankova N, Kippin TE, Kerstetter KA, Neve RL, Haggarty SJ,
McKinsey TA, Bassel-Duby R, Olson EN, Nestler EJ: Histone deacetylase
5 epigenetically controls behavioral adaptations to chronic emotional
stimuli. Neuron 2007, 56:517–529.
8. LaPlant Q, Vialou V, Covington HE, Dumitriu D, Feng J, Warren BL, Maze I,
Dietz DM, Watts EL, Iniguez SD, Koo JW, Mouzon E, Renthal W, Hollis F,Wang H, Noonan MA, Ren Y, Eisch AJ, Bolanos CA, Kabbaj M, Xiao G, Neve
RL, Hurd YL, Oosting RS, Fan G, Morrison JH, Nestler EJ: Dnmt3a regulates
emotional behavior and spine plasticity in the nucleus accumbens.
Nat Neurosci 2010, 13:1137–1143.
9. Maze I, Covington HE, Dietz DM, LaPlant Q, Renthal W, Russo SJ, Mechanic
M, Mouzon E, Neve RL, Haggarty SJ, Ren Y, Sampath SC, Hurd YL, Greengard
P, Tarakhovsky A, Schaefer A, Nestler EJ: Essential role of the histone
methyltransferase G9a in cocaine-induced plasticity. Science 2010,
327:213–216.
10. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM, Wood MA: Modulation of
chromatin modification facilitates extinction of cocaine-induced conditioned
place preference. Biol Psychiatry 2010, 67:36–43.
11. Kumar A, Choi K-H, Renthal W, Tsankova NM, Theobald DEH, Truong H-T,
Russo SJ, LaPlant Q, Sasaki TS, Whistler KN, Neve RL, Self DW, Nestler EJ:
Chromatin remodeling is a key mechanism underlying cocaine-induced
plasticity in striatum. Neuron 2005, 48:303–314.
12. Kennedy PJ, Feng J, Robison AJ, Maze I, Badimon A, Mouzon E,
Chaudhury D, Damez-Werno DM, Haggarty SJ, Han MH, Bassel-Duby R,
Olson EN, Nestler EJ: Class I HDAC inhibition blocks cocaine-induced
plasticity by targeted changes in histone methylation. Nat Neurosci
2013, 16:434–440.
13. Renthal W, Kumar A, Xiao G, Wilkinson M, Covington HE, Maze I, Sikder D,
Robison AJ, LaPlant Q, Dietz DM, Russo SJ, Vialou V, Chakravarty S, Kodadek
TJ, Stack A, Kabbaj M, Nestler EJ: Genome-wide analysis of chromatin
regulation by cocaine reveals a role for sirtuins. Neuron 2009, 62:335–348.
14. Jenuwein T, Allis CD: Translating the histone code. Science 2001,
293:1074–1080.
15. Zhou VW, Goren A, Bernstein BE: Charting histone modifications and the
functional organization of mammalian genomes. Nat Rev Genet 2011,
12:7–18.
16. Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for
transcriptomics. Nat Rev Genet 2009, 10:57–63.
17. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T: Epigenetics in alternative
pre-mRNA splicing. Cell 2011, 144:16–26.
18. Li Q, Lee JA, Black DL: Neuronal regulation of alternative pre-mRNA
splicing. Nat Rev Neurosci 2007, 8:819–831.
19. Park PJ: ChIP-seq: advantages and challenges of a maturing technology.
Nat Rev Genet 2009, 10:669–680.
20. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M: An
integrated encyclopedia of DNA elements in the human genome. Nature
2012, 489:57–74.
21. Barski A, Cuddapah S, Cui K, Roh T-Y, Schones DE, Wang Z, Wei G, Chepelev
I, Zhao K: High-resolution profiling of histone methylations in the human
genome. Cell 2007, 129:823–837.
22. Trapnell C, Pachter L, Salzberg SL: TopHat: discovering splice junctions
with RNA-Seq. Bioinformatics 2009, 25:1105–1111.
23. DeLuca DS, Levin JZ, Sivachenko A, Fennell T, Nazaire M-D, Williams C, Reich
M, Winckler W, Getz G: RNA-SeQC: RNA-seq metrics for quality control
and process optimization. Bioinformatics 2012, 28:1530–1532.
24. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ,
Salzberg SL, Wold BJ, Pachter L: Transcript assembly and quantification by
RNA-Seq reveals unannotated transcripts and isoform switching during
cell differentiation. Nat Biotechnol 2010, 28:511–515.
25. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H,
Salzberg SL, Rinn JL, Pachter L: Differential gene and transcript expression
analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc
2012, 7:562–578.
26. Merico D, Isserlin R, Stueker O, Emili A, Bader GD: Enrichment map: a
network-based method for gene-set enrichment visualization and
interpretation. PLoS One 2010, 5:e13984.
27. Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis
of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,
4:44–57.
28. Huang DW, Sherman BT, Lempicki RA: Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res 2009, 37:1–13.
29. Maze I, Nestler EJ: The epigenetic landscape of addiction. Ann N Y Acad
Sci 2011, 1216:99–113.
30. Shen L, Shao N, Liu X, Nestler E: ngs.plot: Quick mining and visualization
of next-generation sequencing data by integrating genomic databases.
BMC Genomics 2014, 15:284.
Feng et al. Genome Biology 2014, 15:R65 Page 17 of 18
http://genomebiology.com/2014/15/4/R6531. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P,
Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser
A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES,
Bernstein BE: Genome-wide maps of chromatin state in pluripotent and
lineage-committed cells. Nature 2007, 448:553–560.
32. Shen L, Shao N-Y, Liu X, Maze I, Feng J, Nestler EJ: diffReps: detecting
differential chromatin modification sites from ChIP-seq data with biological
replicates. PLoS One 2013, 8:e65598.
33. Ingenuity Pathway Analysis. [http://www.ingenuity.com/]
34. Andersson R, Enroth S, Rada-Iglesias A, Wadelius C, Komorowski J: Nucleosomes
are well positioned in exons and carry characteristic histone modifications.
Genome Res 2009, 19:1732–1741.
35. Spies N, Nielsen CB, Padgett RA, Burge CB: Biased chromatin signatures
around polyadenylation sites and exons. Mol Cell 2009, 36:245–254.
36. Sims RJ, Millhouse S, Chen CF, Lewis BA, Erdjument-Bromage H, Tempst P,
Manley JL, Reinberg D: Recognition of trimethylated histone h3 lysine 4
facilitates the recruitment of transcription postinitiation factors and pre-
mRNA splicing. Mol Cell 2007, 28:665–676.
37. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T: Regulation
of alternative splicing by histone modifications. Science 2010, 327:996–1000.
38. Saint-André V, Batsché E, Rachez C, Muchardt C: Histone H3 lysine 9
trimethylation and HP1γ favor inclusion of alternative exons. Nat Struct
Mol Biol 2011, 18:337–344.
39. Katz Y, Wang ET, Airoldi EM, Burge CB: Analysis and design of RNA
sequencing experiments for identifying isoform regulation. Nat Methods
2010, 7:1009–1015.
40. Anders S, Reyes A, Huber W: Detecting differential usage of exons from
RNA-seq data. Genome Res 2012, 22:2008–2017.
41. Chasin LA: Searching for splicing motifs. Adv Exp Med Biol 2007, 623:85–106.
42. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren JY, Li WW,
Noble WS: MEME SUITE: tools for motif discovery and searching. Nucleic
Acids Res 2009, 37:W202–W208.
43. Zhu H, Hasman RA, Barron VA, Luo G, Lou H: A nuclear function of Hu
proteins as neuron-specific alternative RNA processing regulators.
Mol Biol Cell 2006, 17:5105–5114.
44. Yano M, Okano HJ, Okano H: Involvement of Hu and heterogeneous
nuclear ribonucleoprotein K in neuronal differentiation through p21
mRNA post-transcriptional regulation. J Biol Chem 2005, 280:12690–12699.
45. Merzdorf CS: Emerging roles for zic genes in early development. Dev Dyn
2007, 236:922–940.
46. Kuroyanagi H: Fox-1 family of RNA-binding proteins. Cell Mol Life Sci 2009,
66:3895–3907.
47. Fujii R, Takumi T: TLS facilitates transport of mRNA encoding an actin-
stabilizing protein to dendritic spines. J Cell Sci 2005, 118:5755–5765.
48. Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T, Nishikawa
T, Hicks GG, Takumi T: The RNA binding protein TLS is translocated to
dendritic spines by mGluR5 activation and regulates spine morphology.
Curr Biol 2005, 15:587–593.
49. McClellan KA, Ruzhynsky VA, Douda DN, Vanderluit JL, Ferguson KL, Chen D,
Bremner R, Park DS, Leone G, Slack RS: Unique requirement for Rb/E2F3 in
neuronal migration: evidence for cell cycle-independent functions.
Mol Cell Biol 2007, 27:4825–4843.
50. Chen D, Pacal M, Wenzel P, Knoepfler PS, Leone G, Bremner R: Division and
apoptosis of E2f-deficient retinal progenitors. Nature 2009, 462:925–929.
51. Ferguson D, Koo JW, Feng J, Heller E, Rabkin J, Heshmati M, Renthal W,
Neve R, Liu X, Shao N, Sartorelli V, Shen L, Nestler EJ: Essential role of SIRT1
signaling in the nucleus accumbens in cocaine and morphine action.
J Neurosci 2013, 33:16088–16098.
52. Davis S, Bozon B, Laroche S: How necessary is the activation of the immediate
early gene zif268 in synaptic plasticity and learning? Behav Brain Res 2003,
142:17–30.
53. Shibata H, Huynh DP, Pulst SM: A novel protein with RNA-binding motifs
interacts with ataxin-2. Hum Mol Genet 2000, 9:1303–1313.
54. Bhalla K, Phillips HA, Crawford J, McKenzie OL, Mulley JC, Eyre H, Gardner AE,
Kremmidiotis G, Callen DF: The de novo chromosome 16 translocations of
two patients with abnormal phenotypes (mental retardation and epilepsy)
disrupt the A2BP1 gene. J Hum Genet 2004, 49:308–311.
55. Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, Lamb J, Bailey AJ,
Monaco AP: Candidate-gene screening and association analysis at the
autism-susceptibility locus on chromosome 16p: evidence of association
at GRIN2A and ABAT. Am J Hum Genet 2005, 76:950–966.56. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A,
Whichello A, Powell CM, Rao K: Cytogenetic and molecular characterization
of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B
Neuropsychiatr Genet 2007, 144:869–876.
57. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B,
Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee Y-H, Hicks J,
Spence SJ, Lee AT, Puura K, Lehtimäki T, Ledbetter D, Gregersen PK, Bregman J,
Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King M-C, Skuse D, Geschwind
DH, Gilliam TC, et al: Strong association of de novo copy number mutations
with autism. Science 2007, 316:445–449.
58. Gehman LT, Stoilov P, Maguire J, Damianov A, Lin CH, Shiue L, Ares M Jr,
Mody I, Black DL: The splicing regulator Rbfox1 (A2BP1) controls neuronal
excitation in the mammalian brain. Nat Genet 2011, 43:706–711.
59. Amir-Zilberstein L, Blechman J, Sztainberg Y, Norton WH, Reuveny A,
Borodovsky N, Tahor M, Bonkowsky JL, Bally-Cuif L, Chen A, Levkowitz G:
Homeodomain protein otp and activity-dependent splicing modulate
neuronal adaptation to stress. Neuron 2012, 73:279–291.
60. Lee JA, Tang ZZ, Black DL: An inducible change in Fox-1/A2BP1 splicing
modulates the alternative splicing of downstream neuronal target exons.
Genes Dev 2009, 23:2284–2293.
61. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor
RM, Blencowe BJ, Geschwind DH: Transcriptomic analysis of autistic brain
reveals convergent molecular pathology. Nature 2011, 474:380–384.
62. Grant CE, Bailey TL, Noble WS: FIMO: scanning for occurrences of a given
motif. Bioinformatics 2011, 27:1017–1018.
63. Licatalosi DD, Darnell RB: Splicing regulation in neurologic disease. Neuron
2006, 52:93–101.
64. Ranum LP, Cooper TA: RNA-mediated neuromuscular disorders. Annu Rev
Neurosci 2006, 29:259–277.
65. Hishimoto A, Liu QR, Drgon T, Pletnikova O, Walther D, Zhu XG, Troncoso
JC, Uhl GR: Neurexin 3 polymorphisms are associated with alcohol
dependence and altered expression of specific isoforms. Hum Mol Genet
2007, 16:2880–2891.
66. Mains RE, Kiraly DD, Eipper-Mains JE, Ma XM, Eipper BA: Kalrn promoter
usage and isoform expression respond to chronic cocaine exposure.
BMC Neurosci 2011, 12:20.
67. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC, Sadee W:
Intronic polymorphisms affecting alternative splicing of human
dopamine D2 receptor are associated with cocaine abuse.
Neuropsychopharmacology 2011, 36:753–762.
68. Schor IE, Rascovan N, Pelisch F, Allo M, Kornblihtt AR: Neuronal cell
depolarization induces intragenic chromatin modifications affecting
NCAM alternative splicing. Proc Natl Acad Sci U S A 2009, 106:4325–4330.
69. Fogel BL, Wexler E, Wahnich A, Friedrich T, Vijayendran C, Gao FY, Parikshak
N, Konopka G, Geschwind DH: RBFOX1 regulates both splicing and
transcriptional networks in human neuronal development. Hum Mol
Genet 2012, 21:4171–4186.
70. Lee AY, Chen W, Stippec S, Self J, Yang F, Ding XJ, Chen S, Juang YC, Cobb
MH: Protein kinase WNK3 regulates the neuronal splicing factor Fox-1.
Proc Natl Acad Sci U S A 2012, 109:16841–16846.
71. Marques F, Sousa J, Coppola G, Gao F, Puga R, Brentani H, Geschwind D,
Sousa N, Correia-Neves M, Palha J: Transcriptome signature of the adult
mouse choroid plexus. Fluids Barriers CNS 2011, 8:10.
72. Li X, Buxbaum J: Transthyretin and the brain re-visited: Is neuronal
synthesis of transthyretin protective in Alzheimer's disease? Mol
Neurodegener 2011, 6:79.
73. Hovatta I, Zapala M, Broide R, Schadt E, Libiger O, Schork N, Lockhart D,
Barlow C: DNA variation and brain region-specific expression profiles
exhibit different relationships between inbred mouse strains: implications
for eQTL mapping studies. Genome Biol 2007, 8:R25.
74. Bowyer J, Patterson T, Saini U, Hanig J, Thomas M, Camacho L, George N, Chen J:
Comparison of the global gene expression of choroid plexus and meninges
and associated vasculature under control conditions and after pronounced
hyperthermia or amphetamine toxicity. BMC Genomics 2013, 14:147.
75. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE,
Nussbaum C, Myers RM, Brown M, Li W, Liu XS: Model-based Analysis of
ChIP-Seq (MACS). Genome Biol 2008, 9:9.
76. Ohnishi YN, Ohnishi YH, Hokama M, Nomaru H, Yamazaki K, Tominaga Y,
Sakumi K, Nestler EJ, Nakabeppu Y: FosB is essential for the enhancement
of stress tolerance and antagonizes locomotor sensitization by
DeltaFosB. Biol Psychiatry 2011, 70:487–495.
Feng et al. Genome Biology 2014, 15:R65 Page 18 of 18
http://genomebiology.com/2014/15/4/R6577. Vialou V, Robison AJ, LaPlant QC, Covington HE III, Dietz DM, Ohnishi YN,
Mouzon E, Rush AJ III, Watts EL, Wallace DL: [Delta] FosB in brain reward
circuits mediates resilience to stress and antidepressant responses. Nat
Neurosci 2010, 13:745–752.
78. Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical
and powerful approach to multiple testing. J R Stat Soc B-Method 1995,
57:289–300.
79. Jensen ST, Liu JS: Bayesian clustering of transcription factor binding
motifs. J Am Stat Assoc 2008, 103:188–200.
doi:10.1186/gb-2014-15-4-r65
Cite this article as: Feng et al.: Chronic cocaine-regulated epigenomic
changes in mouse nucleus accumbens. Genome Biology 2014 15:R65.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
